A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma
Crossref DOI link: https://doi.org/10.1186/s40425-016-0194-1
Published Online: 2016-12-20
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brohl, Andrew S.
Khushalani, Nikhil I.
Eroglu, Zeynep
Markowitz, Joseph
Thapa, Ram
Chen, Y. Ann
Kudchadkar, Ragini
Weber, Jeffrey S.
Funding for this research was provided by:
Merck